Filtros de búsqueda

Lista de obras de

"HER majesty's a pretty nice girl but she changes from day to day".

artículo científico publicado en 2011

A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels

artículo científico publicado en 2004

A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice Context

artículo científico publicado en 2019

A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer.

artículo científico publicado en 2016

A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer

artículo científico publicado en 2018

A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer

artículo científico publicado en 2017

A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.

artículo científico publicado en 2016

A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy

artículo científico publicado en 2014

A novel antimetabolite: TAS-102 for metastatic colorectal cancer

artículo científico

A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity

scientific article published on 01 June 2003

A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.

artículo científico publicado en 2018

A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer

scientific article published on 23 July 2019

A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

scientific article published on 14 June 2019

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.

artículo científico publicado en 2011

A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction

scientific article published on 04 September 2019

A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression

artículo científico publicado en 2006

A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas

artículo científico publicado en 2012

A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma

scientific article published on 08 March 2018

A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors

artículo científico publicado en 2013

A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine

artículo científico publicado en 2015

A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy

artículo científico publicado en 2010

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma

artículo científico publicado en 2011

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study

artículo científico publicado en 2004

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

artículo científico publicado en 2009

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.

artículo científico publicado en 2011

A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials

scientific article published on 16 April 2020

A polymorphism within the vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab or FOLFIRI/cetuximab

artículo científico publicado en 2017

A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases

artículo científico publicado en 2006

A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer

artículo científico publicado en 2014

A review of excision repair cross-complementation group 1 in colorectal cancer.

artículo científico publicado en 2011

A revised nomenclature for the lemur family of protein kinases

artículo científico publicado en 2024

A small cog in a big wheel: PIK3CA mutations in colorectal cancer.

artículo científico publicado en 2013

ABCB1, SLCO1B1 and UGT1A1 gene polymorphisms are associated with toxicity in metastatic colorectal cancer patients treated with first-line irinotecan

artículo científico publicado en 2007

ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer.

artículo científico publicado en 2014

Accomplishments in 2007 in biologic markers for gastrointestinal cancers

artículo científico publicado en 2008

Activity of sunitinib in patients with advanced neuroendocrine tumors

artículo científico publicado en 2008

Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.

scientific article published on July 2007

An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma

artículo científico publicado en 2016

Andecaliximab/GS-5745 alone and combined with mFOLFOX6 in advanced gastric and gastroesophageal junction adenocarcinoma: Results from a phase 1 study.

artículo científico publicado en 2018

Angiogenesis as a target in colorectal cancer therapy. Introduction

artículo científico publicado en 2004

Angiogenesis inhibitors in the treatment of colorectal cancer

artículo científico publicado en 2004

Angiogenesis-related agents in esophageal cancer

artículo científico

Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events

artículo científico publicado en 2006

Antiangiogenic agents in cancer therapy.

artículo científico publicado en 2005

Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A

artículo científico publicado en 2019

Assessing the in vivo efficacy of biologic antiangiogenic therapies

artículo científico

Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study

artículo científico publicado en 2005

Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study

scientific article published on 10 May 2018

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer

artículo científico publicado en 2002

Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer

artículo científico publicado en 2007

Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405

scientific article published on 13 August 2019

Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials.

artículo científico publicado en 2017

B cell and B cell-related pathways for novel cancer treatments

scientific article published on 03 December 2018

Beyond KRAS: a new approach in metastatic colorectal cancer.

artículo científico publicado en 2010

Biomarker in Colorectal Cancer.

artículo científico publicado en 2016

Biomarker-driven and molecular targeted therapies for colorectal cancers

scientific article published on 04 July 2017

Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer

artículo científico publicado en 2011

Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database.

artículo científico publicado en 2015

Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405

artículo científico publicado en 2020

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Bortezomib plus docetaxel in advanced non-small cell lung cancer and other solid tumors: a phase I California Cancer Consortium trial.

artículo científico publicado en 2006

Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study

artículo científico publicado en 2008

CDX2 as a Prognostic Biomarker in Colon Cancer.

artículo científico publicado en 2016

CXCR2 inhibition enhances sulindac-mediated suppression of colon cancer development

artículo científico publicado en 2014

Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.

artículo científico publicado en 2005

Cancer dormancy: a model of early dissemination and late cancer recurrence.

artículo científico publicado en 2011

Capecitabine: the new generation of fluoropyrimidines in colorectal cancer

artículo científico publicado en 2004

Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713.

artículo científico publicado en 2017

Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: a phase II Southwest Oncology Group Study (S0415)

artículo científico publicado en 2010

Cetuximab in the management of colorectal cancer

artículo científico publicado en 2007

Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414)

artículo científico publicado en 2012

Characteristics of Lynch syndrome in 13 Hispanic Families.

artículo científico publicado en 2010

Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer

scientific article published on May 2009

Clinical determinants of response to irinotecan-based therapy derived from cell line models

artículo científico publicado en 2008

Clinical protocol. Tumor site specific phase I evaluation of safety and efficacy of hepatic arterial infusion of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct as intervention for colorectal carcinoma metastatic

scientific article published on 01 August 2002

Clinical update: proteasome inhibitors in solid tumors ⬇️

artículo científico publicado el 1 de mayo de 2003

Clinical validation of a machine-learning derived signature predictive of outcomes from first-line oxaliplatin-based chemotherapy in advanced colorectal cancer

scientific article published on 08 December 2020

Colon cancer stem cells: a new target in the war against cancer

artículo científico publicado en 2008

Colorectal cancer

scholarly article

Colorectal cancer in 2017: Practice-changing updates in the adjuvant and metastatic setting

artículo científico publicado en 2017

Colorectal cancer: Overcoming resistance to anti-EGFR therapy - where do we stand?

artículo científico publicado en 2016

Colorectal cancer: epigenetic alterations and their clinical implications.

artículo científico publicado en 2017

Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer

artículo científico publicado en 2008

Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer

artículo científico publicado en 2020

Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer

artículo científico publicado en 2016

Common cancer stem cell gene variants predict colon cancer recurrence.

artículo científico publicado en 2011

Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma

artículo científico publicado en 2018

Comparative effectiveness of screening strategies for colorectal cancer.

artículo científico publicado en 2017

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers.

artículo científico publicado en 2017

Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma

artículo científico publicado en 2020

Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU).

artículo científico publicado en 2007

Conversations About Financial Issues in Routine Oncology Practices: A Multicenter Study

artículo científico publicado en 2019

Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer

scientific article published on 19 December 2019

Current multidisciplinary oncology series.

artículo científico publicado en 2014

Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab

artículo científico publicado en 2006

Cyclooxygenase-2 inhibitors in colorectal cancer

artículo científico publicado en 2003

Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach

artículo científico publicado en 2015

DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.

artículo científico publicado en 2009

DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer

artículo científico publicado en 2017

Determinants of chemosensitivity in gastric cancer

artículo científico publicado en 2006

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response.

artículo científico publicado en 2017

Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)

artículo científico publicado en 2019

Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer.

artículo científico publicado en 2018

Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group study

artículo científico publicado en 2007

Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study

artículo científico publicado en 2011

Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotini

artículo científico publicado en 2014

EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients

artículo científico publicado en 2011

EGFR signaling and drug discovery.

artículo científico publicado en 2009

EGFR, HER2 and VEGF pathways: validated targets for cancer treatment

artículo científico publicado en 2007

EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer

artículo científico publicado en 2008

ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis

artículo científico publicado en 2011

ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.

artículo científico publicado en 2003

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

artículo científico publicado en 2016

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.

artículo científico publicado en 2017

Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer

artículo científico publicado en 2006

Epidermal growth factor receptor as a target for chemotherapy

artículo científico publicado en 2005

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.

artículo científico publicado en 2005

Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib

artículo científico publicado en 2020

Explaining the unexplainable: EGFR antibodies in colorectal cancer

artículo científico publicado en 2012

Exploring alternative individualized treatment strategies in colorectal cancer.

artículo científico publicado en 2007

Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection.

artículo científico publicado en 2016

FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study.

artículo científico publicado en 2014

FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.

artículo científico publicado en 2007

Familial Adenomatous Polyposis (FAP) in 9 Hispanic women.

artículo científico publicado en 2010

First Amsterdam, then Bethesda, now Melbourne?

artículo científico publicado en 2005

First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors

artículo científico publicado en 2018

First-line combination treatment of colorectal cancer with hepatic metastases: choosing a targeted agent

artículo científico publicado en 2008

Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer

artículo científico publicado en 2015

Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types.

artículo científico publicado en 2018

Gender disparities in metastatic colorectal cancer survival

artículo científico publicado en 2009

Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer

artículo científico publicado en 2008

Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.

scientific article published on January 2011

Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib.

artículo científico publicado en 2018

Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation

artículo científico publicado en 2006

Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancer

artículo científico publicado en 2006

Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer

artículo científico publicado en 2005

Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials

artículo científico publicado en 2022

Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer

artículo científico publicado en 2015

Genetic variation in TET3 and survival in metastatic colorectal cancer (mCRC) from FIRE-3, TRIBE, and MAVERICC clinical trials

Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus

artículo científico publicado en 2010

Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases.

artículo científico publicado en 2015

Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy

scientific article published on 27 November 2019

Genome-wide association study of colorectal cancer in Hispanics

artículo científico publicado en 2016

Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)

scientific article published on 21 September 2020

Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.

artículo científico publicado en 2006

Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients ⬇️

artículo científico publicado el 8 de octubre de 2010

Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma ⬇️

artículo científico publicado el 11 de febrero de 2011

Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses

artículo científico publicado en 2019

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

artículo científico publicado en 2006

High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma

scientific article published on 10 July 2019

Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells.

artículo científico publicado en 2009

IL-33 activates tumor stroma to promote intestinal polyposis.

artículo científico publicado en 2015

Identification of a Genomic Region between and Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)

artículo científico publicado en 2018

Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer

artículo científico publicado en 2012

Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases

artículo científico publicado en 2020

Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer

scientific article published on 23 August 2018

Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)

artículo científico publicado en 2019

Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors

artículo científico publicado en 2018

Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3

artículo científico publicado en 2019

Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer

scientific article published on 29 November 2018

Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.

artículo científico publicado en 2014

Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012.

artículo científico publicado en 2016

Implications of Genetic Testing in the Management of Colorectal Cancer

artículo científico publicado el 1 de enero de 2003

Individualization of therapy for colorectal cancer based on clinical and molecular parameters

scientific article published on July 2008

Influence of sex on the survival of patients with esophageal cancer.

artículo científico publicado en 2012

Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancer

artículo científico publicado en 2011

Integrating biomarkers into clinical decision making for colorectal cancer

artículo científico publicado en 2010

Integration of novel agents in the treatment of colorectal cancer

artículo científico publicado en 2004

Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients

scientific article published on 28 August 2015

Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models.

artículo científico publicado en 2011

Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration.

artículo científico publicado en 2012

Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial

artículo científico publicado en 2005

Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardia

artículo científico publicado el 1 de septiembre de 2003

Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics

artículo científico publicado en 2009

KRAS mutation in metastatic colorectal cancer and its impact on the use of EGFR inhibitors

artículo científico publicado en 2008

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.

artículo científico publicado en 2011

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.

artículo científico publicado en 2011

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

artículo científico publicado en 2018

Listening in on difficult conversations: an observational, multi-center investigation of real-time conversations in medical oncology

artículo científico publicado en 2013

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer

scientific article published on 17 September 2018

Management and preparedness for infusion and hypersensitivity reactions

artículo científico publicado en 2007

Management of Advanced Small Bowel Cancer

artículo científico publicado en 2018

Markers of response for the antiangiogenic agent bevacizumab

artículo científico publicado en 2013

Messenger RNA expression of COX-2 and angiogenic factors in primary colorectal cancer and corresponding liver metastasis

artículo científico publicado en 2009

Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis

artículo científico publicado en 2008

Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasis

artículo científico publicado en 2008

Metastatic Colorectal Cancer in Hispanics: Treatment Outcomes in a Treated Population

artículo científico publicado en 2016

MicroRNA-21 in colorectal cancer: "Just another brick in the wall"?

artículo científico publicado en 2013

Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives

artículo científico publicado en 2018

Mindfulness practice reduces cortisol blunting during chemotherapy: A randomized controlled study of colorectal cancer patients

artículo científico publicado en 2017

Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal Cancer

scientific article published on 17 December 2019

Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer.

artículo científico publicado en 2016

Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment

artículo científico publicado en 2016

Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor.

artículo científico publicado en 2015

Molecular Predictors of Response to Antiangiogenesis Therapies ⬇️

artículo científico publicado el 1 de marzo de 2011

Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer

artículo científico publicado en 2019

Molecular Response Prediction in Multimodality Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction ⬇️

artículo científico publicado el 1 de enero de 2010

Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions.

artículo científico publicado en 2018

Molecular characterization of appendiceal goblet cell carcinoid

scientific article published on 09 October 2020

Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network

artículo científico

Molecular determinants of cetuximab efficacy

artículo científico publicado en 2005

Molecular determinants of irinotecan efficacy.

artículo científico publicado en 2006

Molecular insight of regorafenib treatment for colorectal cancer

scientific article published on 28 October 2019

Molecular markers in gastrointestinal cancer: targeted therapy and tailored chemotherapy.

artículo científico publicado en 2004

Molecular markers in the treatment of metastatic colorectal cancer.

artículo científico publicado en 2010

Molecular pathways: Estrogen pathway in colorectal cancer.

artículo científico publicado en 2013

Molecular pathways: turning proteasomal protein degradation into a unique treatment approach

artículo científico publicado en 2014

Molecular predictive and prognostic markers in colon cancer

artículo científico publicado en 2010

Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study)

artículo científico publicado el 1 de octubre de 2010

Molecular predictors of treatment and outcome in colorectal cancer

artículo científico publicado en 2003

Molecular prognostic markers in locally advanced colon cancer

artículo científico publicado en 2007

Molecular variations between small bowel adenocarcinomas (SBAs), right-sided colon cancers (RT-Colon), and gastroesophageal cancers (GEC)

scientific article published on 01 June 2017

Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy

artículo científico publicado en 2010

Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients

artículo científico publicado en 2013

Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors

artículo científico publicado en 2014

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

artículo científico publicado en 2006

Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma

artículo científico publicado en 2006

Mutant DNA in plasma of lung cancer patients: potential for monitoring response to therapy

artículo científico publicado en 2004

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers

artículo científico

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome

scientific article published on 13 March 2019

NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.

artículo científico publicado en 2018

New perspectives for colorectal cancer

artículo científico publicado en 2017

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.

artículo científico publicado en 2017

Non-coding RNAs derived from an alternatively spliced REST transcript (REST-003) regulate breast cancer invasiveness

artículo científico publicado en 2015

Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer

artículo científico publicado en 2019

Novel Common Genetic Susceptibility Loci for Colorectal Cancer

artículo científico publicado en 2019

Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies

artículo científico publicado en 2006

Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications

artículo científico publicado en 2016

Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims

artículo científico publicado en 2019

Outlook: Immunotherapy in Gastrointestinal Carcinoma - Innovative Strategies.

artículo científico publicado en 2018

Outlooks on Epstein-Barr virus associated gastric cancer.

artículo científico publicado en 2018

Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies

artículo científico publicado en 2020

Pancreatic cancer: medical management (novel chemotherapeutics).

artículo científico publicado en 2012

Panitumumab : leading to better overall survival in metastatic colorectal cancer?

artículo científico

Panitumumab safety for treating colorectal cancer

artículo científico publicado en 2014

Partition: a surjective mapping approach for dimensionality reduction

artículo científico publicado en 2020

Patient Care Satisfaction and Emergency Room Utilization among Young Adult Colorectal Cancer Survivors during the SARS-CoV-2 Pandemic: Lessons Learned

artículo científico publicado en 2023

Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results

artículo científico publicado en 2014

Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial

artículo científico publicado en 2015

Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation

artículo científico publicado en 2015

Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer

artículo científico publicado en 2011

Pharmacogenetic aspects in treatment of colorectal cancer – an update ⬇️

artículo científico publicado el 1 de noviembre de 2003

Pharmacogenomics and -genetics in colorectal cancer

artículo científico publicado en 2008

Pharmacogenomics and colorectal cancer

artículo científico publicado en 2006

Pharmacogenomics and metastatic colorectal cancer: current knowledge and perspectives

artículo científico

Pharmacogenomics in colorectal cancer ⬇️

artículo científico publicado el 1 de agosto de 2003

Pharmacogenomics of fluorouracil -based chemotherapy toxicity

artículo científico

Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the national cancer institute organ dysfunction working group ⬇️

artículo científico publicado el 1 de agosto de 2003

Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer.

artículo científico publicado en 2014

Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation.

artículo científico publicado en 2013

Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group

artículo científico publicado en 2008

Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule

artículo científico publicado en 2005

Phase I clinical trial of pegylated liposomal Doxorubicin and docetaxel in patients with advanced solid tumors

artículo científico publicado en 2011

Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis

artículo científico publicado en 2006

Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial

artículo científico publicado en 2002

Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study.

artículo científico publicado en 2013

Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study ⬇️

artículo científico publicado en 2009

Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial

scientific article published on 14 September 2019

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)

scientific article published on 14 December 2018

Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer

artículo científico publicado en 2016

Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer

artículo científico publicado en 2003

Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia

artículo científico publicado en 2008

Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study

artículo científico publicado en 2005

Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study

artículo científico publicado en 2006

Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer

artículo científico publicado en 2009

Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial

artículo científico publicado en 2008

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study

artículo científico publicado en 2006

Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study ⬇️

artículo científico publicado el 9 de octubre de 2010

Phase II trial of neoadjuvant bevacizumab with modified FOLFOX7 (BEVmFOLFOX) in Patients (pts) with stage II and III rectal adenocarcinoma (RCA)

scientific article published on 01 June 2017

Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy

artículo científico publicado en 2007

Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.

artículo científico publicado en 2009

Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)

scientific article published on 23 September 2019

Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.

artículo científico publicado en 2013

Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab

artículo científico publicado en 2008

Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab

artículo científico publicado en 2008

Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among patients with stage II or III rectal cancer (INT-0144; SWOG 9304).

artículo científico publicado en 2014

Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer

artículo científico publicado en 2009

Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer

scientific article published on 21 June 2018

Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer.

artículo científico publicado en 2017

Predictive and prognostic markers in colorectal cancer.

artículo científico publicado en 2007

Predictive and prognostic markers in the treatment of metastatic colorectal cancer (mCRC): personalized medicine at work

artículo científico publicado en 2015

Predictive molecular classifiers in colorectal cancer.

artículo científico

Primary tumor location as a prognostic factor in metastatic colorectal cancer.

artículo científico publicado en 2015

Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy

scientific article published on 13 September 2018

Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy

artículo científico publicado en 2016

Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.

artículo científico publicado en 2018

Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials

artículo científico

Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients

artículo científico publicado en 2014

Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States

artículo científico publicado en 2013

Prognostic/Predictive molecular markers in colorectal cancer.

artículo científico publicado en 2007

Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab

artículo científico publicado en 2013

Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!

artículo científico publicado en 2013

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

scientific article published on 23 September 2019

Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products.

artículo científico publicado en 2003

Quantitative evidence for early metastatic seeding in colorectal cancer

artículo científico publicado en 2019

RAS mutations in colorectal cancer.

artículo científico publicado en 2013

Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer

artículo científico publicado en 2015

Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study

scientific article published on 17 September 2007

Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer.

artículo científico publicado en 2017

Randomized trial of TAS-102 for refractory metastatic colorectal cancer

artículo científico publicado en 2015

Randomized trial of irinotecan and cetuximab (IC) versus irinotecan, cetuximab and ramucirumab (ICR) as 2nd line therapy of advanced colorectal cancer (CRC) following oxaliplatin and bevacizumb based therapy: Result of E7208

scientific article published on 01 June 2018

Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201

artículo científico publicado en 2019

Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation

artículo científico publicado en 2017

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study

artículo científico publicado en 2019

Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage

artículo científico publicado en 2009

Reply to J. Zhang et al

artículo científico publicado en 2013

Reply to S. Sorscher

scientific article published on 03 July 2019

Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity

scientific article published on 19 November 2018

Response

Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma

artículo científico publicado en 2007

Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial

artículo científico publicado en 2018

Role of cyclin polymorphisms in predicting outcome of 5-fluorouracil-based chemotherapy in colorectal cancer: one piece in a complex puzzle.

artículo científico publicado en 2013

S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma

artículo científico publicado en 2011

SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.

artículo científico publicado en 2003

SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma

artículo científico publicado en 2011

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin

artículo científico publicado en 2013

Safely targeting cancer stem cells via selective catenin coactivator antagonism

artículo científico

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

scientific article published on 01 November 2019

Safety and Tolerability of c-MET Inhibitors in Cancer

artículo científico publicado en 2019

Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors

artículo científico publicado en 2005

Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer

artículo científico publicado en 2003

Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer

artículo científico publicado en 2019

Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors

artículo científico publicado en 2007

Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells

Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients

artículo científico publicado en 2007

Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)

artículo científico publicado en 2020

Shared heritability and functional enrichment across six solid cancers

artículo científico publicado en 2019

Shared heritability and functional enrichment across six solid cancers

Should continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe?

artículo científico publicado en 2006

Single cell correlation analysis of liquid and solid biopsies in metastatic colorectal cancer

scientific article published on 17 December 2019

Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent.

artículo científico publicado en 2014

Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.

artículo científico publicado en 2017

So much effort, so little progress?

artículo científico publicado en 2014

Standing the test of time: targeting thymidylate biosynthesis in cancer therapy

artículo científico publicado en 2014

Stem cells in colon cancer

artículo científico publicado en 2008

Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity

artículo científico publicado en 2011

Sustained inhibition of deacetylases is required for the antitumor activity of the histone deactylase inhibitors panobinostat and vorinostat in models of colorectal cancer.

artículo científico publicado en 2013

Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement

artículo científico publicado en 2012

TAS-102, a novel antitumor agent: a review of the mechanism of action

artículo científico

TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy

artículo científico publicado en 2016

Tailored chemotherapy for colorectal cancer: a new approach to therapy

artículo científico publicado en 2004

Tailoring chemotherapy in advanced colorectal cancer

artículo científico publicado en 2003

Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

artículo científico publicado en 2017

Targeted therapies: Cetuximab dosing by rash--is the scaling of EVEREST meaningful?

scientific article published on 14 August 2012

Targeted therapy and pharmacogenomic programs

artículo científico publicado en 2003

Targeting IL-8 in colorectal cancer

artículo científico publicado en 2012

Targeting metastatic colorectal cancer in 2008: a long way from 5-FU.

artículo científico publicado en 2008

Testing for RAS mutations in patients with metastatic colorectal cancer

artículo científico publicado en 2014

The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma

artículo científico publicado en 2002

The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer

artículo científico publicado en 2009

The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models

artículo científico publicado en 2012

The colorectal cancer disease-specific transcriptome may facilitate the discovery of more biologically and clinically relevant information

artículo científico publicado en 2010

The continuum of care: a paradigm for the management of metastatic colorectal cancer

artículo científico publicado en 2007

The current state of molecular testing in the treatment of patients with solid tumors, 2019

scientific article published on 22 May 2019

The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.

artículo científico publicado en 2009

The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models.

artículo científico publicado en 2011

The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer

scientific article published on 28 June 2019

The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.

artículo científico publicado en 2014

The potential of targeting Wnt/β-catenin in colon cancer

artículo científico publicado en 2014

The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study

artículo científico publicado en 2008

The role of proteasome inhibitors in solid tumors

artículo científico publicado en 2004

The safety and efficacy of trifluridine-tipiracil for metastatic colorectal cancer: A pharmacy perspective

scientific article published on 01 February 2019

The safety of monoclonal antibodies for treatment of colorectal cancer

artículo científico publicado en 2016

The structure-function relationship of oncogenic LMTK3

artículo científico publicado en 2020

The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer

artículo científico publicado en 2017

The use and development of germline polymorphisms in clinical oncology

artículo científico publicado en 2004

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer

artículo científico publicado en 2002

Thymidylate synthase gene variations: predictive and prognostic markers

artículo científico publicado en 2009

Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer

artículo científico publicado en 2008

Timeliness of adjuvant chemotherapy for stage III adenocarcinoma of the colon: a measure of quality of care

artículo científico publicado en 2013

Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study

artículo científico publicado en 2003

Trends in colorectal cancer mortality in hispanics: a SEER analysis

artículo científico publicado en 2017

Tumor sidedness and enriched gene groups for efficacy of first-line cetuximab treatment in metastatic colorectal cancer

article

Understanding the FOLFOXIRI-regimen to optimize treatment for metastatic colorectal cancer

artículo científico publicado en 2016

Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes

artículo científico

Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer

artículo científico publicado en 2010

What Should We Do Better? Lessons from Negative Results of a Biomarker Validation Study

artículo científico publicado en 2019

What We Know About Stage II and III Colon Cancer: It's Still Not Enough

artículo científico publicado en 2017

What roles do colon stem cells and gap junctions play in the left and right location of origin of colorectal cancers?

artículo científico publicado en 2017

ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda